Board of Directors
President
- Nakayama George
- Senior Adviser
- Daiichi Sankyo Co., Ltd.
Vice President
- Okada Yasushi
- Representative Corporate Officer, COO and Industry Affairs
- Eisai Co., Ltd.
- Yasukawa Kenji,Ph.D.
- President and CEO
- Astellas Pharma Inc.
- Teshirogi Isao,Ph.D.
- President and Representative Director
- Shionogi & Co., Ltd.
- Tada Masayo
- Representative Director,Chairman
- Sumitomo Dainippon Pharma Co., Ltd
- Iwasaki Masato,Ph.D.
- President,Japan Pharma Business Unit
- Takeda Pharmaceutical Co., Ltd.
- Ueno Hiroaki
- President & Representative Director, Chief Executive Officer
- Mitsubishi Tanabe Pharma Co., Ltd.
- Kosaka Tatsuro
- Representative Director, Chairman & CEO
- Chugai Pharmaceutical Co., Ltd.
Standing Director
- Stefan Woxström
- Representative Director and President
- AstraZeneca K.K.
- Paul Lirette
- President & Representative Director
- GlaxoSmithKline K.K.
- Furihata Yoshio
- President and COO
- Kissei Pharmaceutical Co., Ltd.
- Miyamoto Masashi, Ph.D.
- Executive Director of the Board President and Chief Executive Officer
- Kyowa Kirin Co., Ltd.
- Hiromichi Shirasawa, MD
- Representative Director and Senior Vice President Head of Japan Development
- MSD Co., Ltd.
- Sagara Gyo
- President and Representative Director Chief Executive Officer
- Ono Pharmaceutical Co., Ltd.
- Morishima Nobuyuki
- Vice President and Representative Director
- Otsuka Pharmaceutical Co., Ltd.
- Harada Akihisa,
M.D.,Ph.D.
- President & Representative Director
- Pfizer Japan Inc.
- Iwaya Takahiko
- President
- Sanofi K.K
Directors
- Aoki Yoshikazu, Ph.D.
- President & CEO
- Asahi kasei Pharma Corporation
- Heike Prinz
- President
- Bayer Yakuhin, Ltd.
- Jean-Christophe Barland
- President
- Bristol-Myers Squibb K.K.
- Simone Thomsen
- Representative Director and President
- Eli Lilly Japan K.K.
- Nakatomi Kazuhide
- President & CEO
- Hisamitsu Pharmaceutical Co., Inc
- Chris Hourigan
- President
- Janssen Pharmaceutical K.K.
- Horiuchi Hiroyuki
- President and Representative Director
- Kaken Pharmaceutical Co., Ltd
- Miwa Yoshihiro
- President and CEO
- Kowa Co., Ltd.
- Ogihara Shigeru
- Representative Director
President and Chief Executive Officer
- Kyorin Pharmaceutical Co., Ltd.
- Kobayashi Daikichiro
- President and Representative Director
- Meiji Seika Pharma Co., Ltd.
- Mochida Naoyuki
- President
- Mochida Pharmaceutical Co., Ltd.
- Aono Yoshiaki
- Representative Director, Chairman and President
- Nippon Boehringer Ingelheim Co., Ltd.
- Maekawa Shigenobu
- President
- Nippon Shinyaku Co., Ltd.
- Leo Lee
- President and Representative Director
- Novartis Pharma K.K
- Kurokawa Akira
- Representative Director,Chairman
- Santen Pharmaceutical Co., Ltd.
- Kobayashi Masayuki
- President
- Taiho Pharmaceutical Co., Ltd.
- Watanabe Ichiro
- President
- Teijin Pharma Limited
- Uehara Shigeru
- Chief Executive Officer
- Taisho Pharmaceutical Co., Ltd.
- Matsuda Goichi
- Representative Director, President and Chief Executive Officer
- Torii Pharmaceutical Co., Ltd.
Auditors
- Yamaguchi Takashi, Ph.D.
- President & Representative Director
- ASKA Pharmaceutical Co., Ltd.
- Ibe Sachiaki
- Chairman & CEO
- Zeria Pharmaceutical Co., Ltd.
Secretariat
- Shiraishi Junichi
- Director General
- Mori Kazuhiko
- Senior Managing Director
- Tanaka Tokuo
- Managing Director
- Nakagawa Sachiko
- Managing Director
Page Top
